文献速递造血干细胞移植与细胞治疗

Delta样配体1和4介导的Notch信号控制小鼠慢性GVHD的发病机制

Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.
PubMed 文献 · Blood · 2018-09-04

该研究利用遗传和抗体介导的Notch抑制策略,在模拟人慢性GVHD(cGVHD)多个方面的互补小鼠模型中探究Notch信号的作用。在B10.D2→BALB/c硬化性cGVHD模型中,Dll4驱动的Notch信号对疾病发生至关重要;在B6→B10.BR多器官系统cGVHD伴闭塞性细支气管炎(BO)模型中,T细胞缺乏Notch信号或系统靶向Dll1、Dll4可提供持久保护。Notch配体和受体是预防或治疗不同形式cGVHD的新型可成药靶点。

要点

  • 在B10.D2→BALB/c硬化性cGVHD模型中,Dll4驱动的Notch信号是疾病发生所必需的。
  • 早期预防性给予抗Dll4抗体获益最大,抗Dll1可增强早期保护。
  • 在B6→B10.BR多器官cGVHD伴BO模型中,系统靶向Dll1、Dll4或两者均可复制T细胞Notch缺失的持久保护。

核心结论

  • Notch配体和受体调控cGVHD的关键致病步骤,是预防或治疗不同形式cGVHD的新型可成药靶点。

研究设计与样本

  • 研究使用遗传和抗体介导的Notch抑制策略,在模拟人cGVHD若干方面的互补小鼠cGVHD模型中探究Notch信号的作用。

主要发现

  • 在B10.D2→BALB/c硬化性cGVHD模型中,Dll4驱动的Notch信号对疾病发生至关重要,早期预防性抗Dll4抑制获益最大,抗Dll1增强早期保护。
  • Notch缺陷的异体抗原特异性T细胞体内早期增殖或辅助极化无缺陷,但随后细胞因子分泌显著减少、FoxP3+调节性T细胞积聚增强。
  • 在B6→B10.BR主要组织相容性复合体错配的多器官系统cGVHD伴显著闭塞性细支气管炎(BO)但无皮肤表现的模型中,T细胞缺乏Notch信号提供持久疾病保护,系统靶向Dll1、Dll4或两者均可复制该保护,即使在疾病已建立时。
  • Notch抑制减少靶器官损伤和生发中心形成;T细胞中Notch1和/或Notch2失活可减轻BO-cGVHD;单独系统靶向Notch2安全且具治疗获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic hematopoietic cell transplantation (allo-HCT) and remains an area of unmet clinical need with few treatment options available. Notch blockade prevents acute GVHD in multiple mouse models, but the impact of Notch signaling on cGVHD remains unknown. Using genetic and antibody-mediated strategies of Notch inhibition, we investigated the role of Notch signaling in complementary mouse cGVHD models that mimic several aspects of human cGVHD in search of candidate therapeutics. In the B10.D2→BALB/c model of sclerodermatous cGVHD, Delta-like ligand 4 (Dll4)-driven Notch signaling was essential for disease development. Antibody-mediated Dll4 inhibition conferred maximum benefits when pursued early in a preventative fashion, with anti-Dll1 enhancing early protection. Notch-deficient alloantigen-specific T cells showed no early defects in proliferation or helper polarization in vivo but subsequently exhibited markedly decreased cytokine secretion and enhanced accumulation of FoxP3+ regulatory T cells. In the B6→B10.BR major histocompatibility complex-mismatched model with multi-organ system cGVHD and prominent bronchiolitis obliterans (BO), but not skin manifestations, absence of Notch signaling in T cells provided long-lasting disease protection that was replicated by systemic targeting of Dll1, Dll4, or both Notch ligands, even during established disease. Notch inhibition decreased target organ damage and germinal center formation. Moreover, decreased BO-cGVHD was observed upon inactivation of Notch1 and/or Notch2 in T cells. Systemic targeting of Notch2 alone was safe and conferred therapeutic benefits. Altogether, Notch ligands and receptors regulate key pathogenic steps in cGVHD and emerge as novel druggable targets to prevent or treat different forms of cGVHD.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Radojcic V, Paz K, Chung J, et al. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice. Blood. 2018. PMID: 30181175. doi:10.1182/blood-2018-03-841155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。